Collectively, our study showed that METTL3 played a crucial role in regulation of TMZ sensitivity via regulating the mRNA stabilities of MGMT and APNG mRNAs in GSCs, which may serve as the potential treatment strategies targeting METTL3 to reverse TMZ resistance against GBM. This evidence concerns the gene MPG and glioblastoma.